Zevra Therapeutics, Inc. ZVRA Q1 2025 earnings
Reported May 13, 2025 · After market close
Revenue$20.4MMiss by $672.6K
EPS-$0.06Beat by $0.15
Revenue estimate$21.1M
EPS estimate-$0.21
Next report
Aug 5, 2026 (In 1 week)Revenue estimate$33.9M
EPS estimate$0.08
Financials
Q1 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Zevra Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Zevra Therapeutics, Inc. report Q1 2025 earnings?
- Zevra Therapeutics, Inc. (ZVRA) reported Q1 2025 earnings on May 13, 2025 after market close.
- What were Zevra Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Zevra Therapeutics, Inc. reported revenue of $20.4M and eps of $-0.06 for Q1 2025.
- Did Zevra Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $21.1M by $672.6K. EPS beat the consensus estimate of $-0.21 by $0.15.
- How did Zevra Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 495.6% from $3.4M a year earlier and eps grew 85.0% from $-0.40.
- Where can I find Zevra Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001437749-25-016523) directly on SEC EDGAR. The filing index links above go to sec.gov.